Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes

Journal of Clinical Investigation

Volumn 114, Issue 7, 2004, Pages 908-916

  Lin, Xueying ^a   Taguchi, Akiko ^a   Park, Sunmin ^a   Kushner, Jake A ^a   Li, Fan ^a   Li, Yedan ^a   White, Morris F ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; APPETITE; ARTICLE; BODY FAT; BODY GROWTH; BODY MASS; BRAIN REGION; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; FEMALE; HYPOTHALAMUS; INSULIN RESISTANCE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 9644260563     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI22217     Document Type: Article

References (57)

1. Zimmet, P., Alberti, K.G., and Shaw, J. 2001. Global and societal implications of the diabetes epidemic. Nature. 414:782-787.
2. Diamond, J. 2003. The double puzzle of diabetes. Nature. 423:599-602.
3. DeFronzo, R.A. 1988. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM [review]. Diabetes. 37:667-687.
4. Shulman, G.I. 2000. Cellular mechanisms of insulin resistance. J. Clin. Invest 106:171-176.
5. White, M.F. 2003. Insulin signaling in health and disease. Science. 302:1710-1711.
6. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
7. Kubota, N., et al. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 49:1880-1889.
8. Previs, S.F., Withers, D.J., Ren, J.M., White, M.F., and Shulman, G.I. 2000. Contrasting effects of IRS-1 vs IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem. 275:38990-38994.
9. Hennige, A.M., et al. 2003. Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes. J. Clin. Invest. 112:1521-1532. doi:10.1172/ JCI200318581.
10. Jhala, U.S., et al. 2003. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev. 17:1575-1580.
11. Kushner, J.A., et al. 2004. Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes. 53:61-66.
12. Kitamura, T., et al. 2002. The forkhead transcription factor Foxo1 links insulin signaling to Pax1 regulation of pancreatic β cell growth. J. Clin. Invest. 110:1839-1847. doi:10.1172/JC1200216857.
13. Kushner, J.A., et al. 2002. Pdx1 restores β cell function in Irs2 knockout mice. J. Clin. Invest. 109:1193-1201. doi:10.1172/JCI200214439.
14. Suzuki, R., et al. 2003. Pdx1 expression in Irs2-deficient mouse beta-cells is regulated in a strain-dependent manner. J. Biol. Chem. 278:43691-43698.
15. Butler, A.A., and Cone, R.D. 2003. Knockout studies defining different roles for melanocortin receptors in energy homeostasis. Ann. N. Y. Acad. Sci. 994:240-245.
16. Farooqi, I.S., et al. 2003. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348:1085-1095.
17. Schwartz, M.W., et al. 2000. Central nervous system control of food intake. Nature. 404:661-671.
18. Qi, Y., et al. 2004. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10:524-529.
19. Myers, M.G., Jr. 2004. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog. Horm. Res. 59:287-304.
20. Woods, S.C., Lotter, B.C., McKay, L.D., and Porte, D., Jr. 1979. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 282:503-505.
21. Schwartz, M., Figlewicz, D.P., Baskin, D.G., Woods, S.C., and Porte, D. 1992. Insulin in the brain: A hormonal regulator of energy balance. Endocr. Rev. 13:387-414.
22. Schwartz, M.W., Baskin, D.G., Kaiyala, K.J., and Woods, S.C. 1999. Model of the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 69:584-596.
23. Bruning, J.C., et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2122-2125.
24. Huszar, D., et al. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:131-141.
25. Obici, S., et al. 2001. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108:1079-1085. doi:10.1172/JCI200112954.
26. Challis, B.G., et al. 2002. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum. Mol. Genet. 11:1997-2004.
27. Yamauchi, T., et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423:762-769.
28. Combs, T.P., et al. 2003. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes. 52:268-276.
29. Spranger, J., et al. 2003. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 361:226-228.
30. Burks, D.J., et al. 2000. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 407:377-382.
31. Gannon, M., Shiota, C., Postic, C., Wright, C.V., and Magnuson, M. 2000. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis. 26:139-142.
32. Cui, Y., et al. 2004. Essential role of STAT3 in body weight and glucose homeostasis. Mol. Cell. Biol. 24:258-269.
33. Schubert, M., et al. 2003. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci. 23:7084-7092.
34. Withers, D.J., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
35. Schwartz, M.W. 2001. Progress in the search for neuronal mechanisms coupling type 2 diabetes to obesity. J. Clin. Invest. 108:963-964. doi:10.1172/ JCI200114127.
36. Lautier, C., et al. 2003. Complex haplotypes of IRS2 gene are associated with severe obesity and reveal heterogeneity in the effect of Gly1057Asp mutation. Hum. Genet. 113:34-43.
37. Ehrmann, D.A., Tang, X., Yoshiuchi, I., Cox, N.J., and Bell, G.I. 2002. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J. Clin. Endocrinol Metab. 87:4297-4300.
38. Stefan, N., et al. 2004. The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function. Diabetologia. 47:759-761.
39. Brubaker, P.L., and Drucker, D.J. 2004. Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology. 145:2653-2659.
40. During, M.J., et al. 2003. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9:1173-1179.
41. Ling, Z., Heimberg, H., Foriers, A., Schuit, F., and Pipeleers, D. 1998. Differential expression of rat insulin I and II messenger ribonucleic acid after prolonged exposure of islet beta-cells to elevated glucose levels. Endocrinology. 139:491-495.
42. Dor, Y., Brown, J., Martinez, O.I., and Melton, DA. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 429:41-46.
43. Kulkarni, R.N., et al. 1999. Tissue-specific knock-out of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
44. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatc beta cell-specific gene knock-outs using Cre recombinase. J Biol. Chem. 274:305-315.
45. Zander, M., Madsbad, S., Madsen, J.L., and Holst, J.J. 2002. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 359:824-830.
46. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and White, M.F. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-42398.
47. Shimomura, I., et al. 2000. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell. 6:77-86.
48. Obici, S., Feng, Z., Karkanias, G., Baskin, D.G., and Rossetti, L. 2002. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5:566-572.
49. Kulkarni, R.N., et al. 2002. beca-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 31:111-115.
50. Niswender, K.D., et al. 2003. Insulin activation of phospharidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes. 52:227-231.
51. Wood, S.A., Allen, N.D., Rossant, J., Auerbach, A., and Nagy, A. 1993. Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature. 365:87-89.
52. Nagy, T.R., and Clair, A.L. 2000. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes. Res. 8:392-398.
53. Fredrich, R.C., et al. 1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1:1311-1314.
54. Kim, J.K., et al. 2001. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 98:7522-7527.
55. Thevenaz, P., Ruttimann, U.E., and Unser, M. 1998. A pyramid approach to subpixel registration based on intentisy. IEEE Trans. Image Process. 7:27-41.
56. MIT Biopolymers Laboratory, http://web.mit.edu/ biopolymers/www/.
57. Li, C., and Wong, W.H. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. U. S. A. 98:31-36.